Encouraging early clinical anti-tumor activity in advanced solid tumors after one-time infusion of IMA203CD8 at a low median dose during ongoing dose escalation, including deep and durable responses ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback